Epstein-Barr virus latency type and spontaneous reactivation predict lytic induction levels

Area of Science:

• Virology
• Immunology
• Oncology

Background:

• Epstein-Barr virus (EBV) establishes lifelong latency in B cells, evading immune detection.
• EBV exhibits diverse gene expression patterns, termed latency types, within tumor cells.
• Spontaneous reactivation from latency can lead to lytic viral transcription.

Purpose of the Study:

• To investigate the relationship between EBV latency types and spontaneous lytic reactivation.
• To determine if latency type and reactivation levels predict response to chemotherapy-induced reactivation.
• To explore implications for personalized medicine in EBV-associated malignancies.

Main Methods:

• RNA deep sequencing was employed to quantify dynamic ranges of lytic transcription.
• Comparison of spontaneous reactivation levels across different EBV latency types and genetic backgrounds.
• Assessment of how latency type and spontaneous reactivation predict induced reactivation by cytotoxic drugs.

Main Results:

• No correlation was found between EBV latency types and spontaneous reactivation among genetically diverse viruses.
• EBV type I cell lines demonstrated higher spontaneous reactivation compared to isogenic type III cultures.
• Latency type and spontaneous reactivation levels were predictive of chemotherapy-induced reactivation.

Conclusions:

• EBV latency type and spontaneous reactivation are key factors influencing viral behavior in tumor cells.
• These viral characteristics can predict the efficacy of chemotherapy in EBV-transformed malignancies.
• Identifying EBV latency type or measuring spontaneous reactivation may guide personalized treatment strategies to control viral production.